Attention Joslin Patients:

Mask wearing and COVID-19 screening will continue at Joslin until further notice. To expedite building entry, please access COVID Pass the day of your on-site appointment to answer screening questions to receive a pass. We encourage all Joslin patients, including kids 5 and over, to get a COVID-19 vaccine and booster shots as recommended.

Also, please see our main COVID-19 web page for important updates regarding the availability of telehealth appointments at Joslin.
The information is available in English and Spanish.

Alert Close

Lori Laffel, MD, MPH, focuses her research and clinical interests on preventing the late complications of type 1 diabetes and preserving the health, normal growth, development and family functioning of children, adolescents and young adults with diabetes.

Under her leadership, the Joslin Clinic Pediatric, Adolescent and Young Adult Section has nearly quadrupled in size, with a large pediatric research program complementing the clinical activities.

Dr. Laffel and her associates have ongoing studies looking at factors that are predictors of persistence and progression of micralbuminuria in childhood type 1 diabetes onset.

A primary focus of Dr. Laffel's research has been the design, implementation, and evaluation of office-based interventions aimed at increasing family involvement in the day-to-day care of youth with diabetes in order to prevent the expected deteriorations in self-care behaviors and glycemic control that usually occur in late adolescence. This effort has had ongoing funding from the National Institutes of Health and private foundations since 1993. Currently, her research interests include the study of the relationship between nutrition and type 1 diabetes, with 5 years of funding from the National Institute of Child Health and Human Development (NICHD). She also serves as Principal Investigator on an investigation examining barriers to sustained Continuous Glucose Monitoring use in youth and a behavioral intervention to facilitate adherence to diabetes management tasks in teens. Both of these investigations are funded by NIH.

Together with collaborator Barbara Anderson, PhD, now at Baylor College of Medicine, Dr. Laffel pioneered the development and implementation of a cost-effective model of care in which a “Care Ambassador” encourages routine clinic attendance and adherence to diabetes management tasks, such as blood glucose monitoring. Her studies have documented a 30-50% reduction in the rate of acute complications, namely severe hypoglycemia, hospitalizations, and emergency room visits, among patients who received the “Care Ambassador” intervention compared with standard care. These successful research efforts have been translated into the routine clinical care for families of children with newly diagnosed diabetes at Joslin and help to form the basis of national and international initiatives. The “Care Ambassador” intervention approach to care also served as the basis for a multi-center clinical trial of the family management of type 1 diabetes in youth funded by the National Institute of Child, Health and Human Development.

Working with colleagues in the section on Genetics and Epidemiology, the section on Complications, and at Brigham and Women's Hospital, Dr. Laffel identified predictors of early kidney disease in young patients. In association with colleagues in Joslin's Section on Genetics and Epidemiology, she found that risk for diabetic nephropathy increases in patients with infrequent medical follow-up and in those whose hemoglobin A1c values exceed a threshold value of 8 percent. These and other findings laid the foundation for prevention and treatment interventions. For example, Dr. Laffel was the lead author of a study that established the use of angiotensin-converting enzyme (ACE) inhibitors as the standard of care to preserve kidney function in certain patients with type 1 diabetes.

In an effort to evaluate new technologies, Dr. Laffel secured funding from the Juvenile Diabetes Research Foundation (JDRF) to evaluate continuous glucose monitoring (CGM) in youth with type 1 diabetes and served as the co-chair of the multi-center JDRF CGM study. She has also worked with students and fellows from the MIT and Harvard informatics training programs to design, implement, and evaluate wireless technologies aimed at increasing adherence in youth and young adults with type 1 diabetes.

With the current epidemic of childhood obesity and type 2 diabetes in youth, Dr. Laffel has expanded her research interests to include the study of effective approaches for the treatment of type 2 diabetes in youth. She serves as Principal Investigator at the Joslin site in a national multi-center clinical trial of type 2 diabetes in youth funded by the National Institute of Diabetes and Digestive and Kidney Diseases.

Tufts University

Graduate School
Harvard School of Public Health, M.P.H.

Medical School
University of Miami School of Medicine

Children's Hospital Boston

Children's Hospital Boston, Pediatric Endocrinology; Joslin Diabetes Center, Diabetes

Board Certification
American Board of Pediatrics: General Pediatrics; Pediatric Endocrinology

  • Pediatric
  • Type 1

Dr. Laffel has received multiple awards, including the 2015 American Diabetes Association Outstanding Physician-Clinician Award, the 2016 Greater Boston Chamber of Commerce Pinnacle Award, and the 2016 University of Miami Miller School of Medicine Hall of Fame Award.

Contact Information

Office Phone

(617) 732-2603

lori.laffel [at]

News Related to Lori Laffel

Joslin Diabetes Center Physicians Recognized in Boston Magazine’s 2022 ‘Top Doctors’

BOSTON – Boston magazine has named 11 physicians and surgeons from four medical specialties affiliated with the Joslin Diabetes Center to its annual ‘Top Doctors’ guide. Drawing from a Castle Connolly...
Read more on Joslin Diabetes Center Physicians Recognized in Boston Magazine’s 2022 ‘Top Doctors’

CDC Prioritizes Vaccines for Type 1 Diabetes; Advocates Hope Mass. Does Too

The Centers for Disease Control and Prevention recently updated its guidance to include it, but Baker has yet to say if the commonwealth will follow suit. Dr. Lori Laffel of the Joslin Diabetes Center...
Read more on CDC Prioritizes Vaccines for Type 1 Diabetes; Advocates Hope Mass. Does Too

Joslin Physicians on Boston Magazine's Top Docs List

Eleven of Joslin's physicians have made Boston Magazine’s 2021 Top Doctors List. Each year, Boston Magazine partners with healthcare researcher Castle Connolly Medical Ltd. to create a list of the...
Read more on Joslin Physicians on Boston Magazine's Top Docs List